Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma
Clinical trial NCT01709162 · TERMINATED
Trial details
- NCT number
- NCT01709162
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-07-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.